4.2. Analysis.
Comparison 4: Subgroup analysis (severity of condition, based on respiratory support at baseline): remdesivir and standard care versus standard care (plus/minus placebo), Outcome 2: In‐hospital mortality at up to day 150
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.